Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of

Robert Harms1, Brenda Morsey, Craig W Boyer

  • 1Department of Surgery-Transplant, University of Nebraska Medical Center, Omaha, Nebraska, United States of America. rharms@unmc.edu

Plos One
|December 11, 2012
PubMed

Insights

Methamphetamine (Meth) disrupts immune homeostasis by decreasing key immune cells like natural killer (NK) cells and T cells. This immune dysregulation may increase infectious disease vulnerability in methamphetamine users.

Area of Science:

  • Immunology
  • Toxicology
  • Neuroscience

Background:

  • Methamphetamine (Meth) abuse is linked to heightened infectious disease risks.
  • Understanding Meth's impact on the immune system is crucial for public health.

Purpose of the Study:

  • To investigate the effects of Meth on leukocyte populations and function.
  • To elucidate the mechanisms underlying Meth-induced immune alterations.

Main Methods:

  • Utilized a murine model simulating chronic Meth consumption.
  • Performed phenotypic analysis of leukocytes using flow cytometry.
  • Examined changes in natural killer (NK) cells, dendritic cells (DCs), monocytes/macrophages, and T cell subsets (CD4 and CD8).

Main Results:

  • Meth administration decreased NK cell abundance and impaired their responsiveness.
  • Reduced populations of dendritic cells (DCs) and Gr-1(high) monocytes/macrophages were observed.
  • Meth affected T cell subsets, decreasing antigen-experienced cells and altering CD4 T cell activation markers.
  • Observed perturbations in Gr-1(low) monocytes/macrophages.

Conclusions:

  • Methamphetamine disrupts immune homeostasis by altering critical leukocyte populations.
  • Meth-induced immune dysregulation may contribute to increased susceptibility to infections in users.
  • Further research is warranted to explore therapeutic strategies targeting Meth-induced immunotoxicity.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...